LIDOCAINE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under base contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of one unit of Lidocaine Hydrochloride Injection (NSN 6505015332656) at a total contract value of $46.86. The award was issued on July 16, 2026, under solicitation SPE2D226F3030, with delivery scheduled for the same date to Electric Boat Corporation in North Stonington, Connecticut, and an alternate delivery point in Groton, Connecticut. The contract specifies FOB destination terms with the contractor responsible for all shipping costs and requires delivery by the fastest traceable means, explicitly prohibiting parcel post. Inspection and acceptance are conducted by the government at the delivery point, with zero tolerance for quantity variance. The awardee is certified as a small, small disadvantaged, and women-owned business, triggering associated reporting and compliance obligations under federal regulations. Packaging and labeling must include the contract and delivery order numbers in block text, though no military standards or preservation requirements are specified. Payment will be processed through the Defense Finance and Accounting Service at a designated Columbus, Ohio address, using an accounting code of BX: 97X4930 5CBX 001 2620 S33189. The contracting officer is Lisa Quinn, with Jayne Do as the administrative contact. The contract is a single-line item delivery order with no options or extensions, and while general federal acquisition compliance is expected, no specific standards, inspection criteria beyond contractual conformance, or DFAR/FAR clauses are detailed in the provided documentation.